View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
October 13, 2013

University Medical Center Groningen selects RayStation for adaptive radiation therapy

University Medical Center Groningen (UMCG) in Groningen, the Netherlands, has selected the RayStation treatment planning system from RaySearch Laboratories and will also initiate a new research collaboration in the field of proton therapy.

By admin-demo

umcg

University Medical Center Groningen (UMCG) in Groningen, the Netherlands, has selected the RayStation treatment planning system from RaySearch Laboratories and will also initiate a new research collaboration in the field of proton therapy.

RaySearch and the department of Radiation Oncology at UMCG have a long-standing research collaboration focused on strategies and tools for adaptive radiation therapy.

UMCG and RaySearch will now partner to introduce adaptive radiation therapy in clinical practice and further refine and assess the methods involved.

UMCG Department of Radiation Oncology chair Professor Johannes A. Langendijk described RaySearch as a pioneer in the development of advanced software tools for radiation therapy, and said that their longstanding cooperation is highly important for the department.

"RayStation is the leading tool on the market for adaptive radiation therapy and we are very excited to start implementing this concept with a significant potential to improve cancer care," Langendijk added.

Adaptive radiation therapy uses repeated imaging to monitor the changes in the patient’s anatomy and with sophisticated software tools these changes are taken into account to continuously adapt the treatment.

This has significant potential to further increase tumour control and at the same time reduce the risk of side effects.

RayStation is RaySearch’s proprietary complete treatment planning system that integrates all of RaySearch’s advanced treatment planning solutions into one flexible system.

"RayStation is the leading tool on the market for adaptive radiation therapy and we are very excited to start implementing this concept with a significant potential to improve cancer care."

It includes functionality such as RaySearch’s algorithms for IMRT and VMAT optimisation, highly accurate dose engines for both photon and proton therapy and will have full support for 4D adaptive radiation therapy.

The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.

RaySearch CEO Johan Löf said that UMCG has proven over the years that it maintains an excellent standard in cancer research.

"I am therefore convinced that this collaboration will be very fruitful and will make meaningful contributions to the area of adaptive radiation therapy which is the most important new concept in radiation therapy," Löf added.

Research and education at the UMCG are funded through the University of Groningen, and the Faculty of Medical Sciences functions as an integral part of the university.

UMCG is one of the largest hospitals in the Netherlands and the largest employer in the northern Netherlands.


Image: The front entrance of the UMCG. Photo courtesy of MigGroningen.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management